Mendelian randomisation studies of type 2 diabetes: Future prospects

Diabetologia

Volumn 51, Issue 2, 2008, Pages 211-213

  Sandhu, M S ^a,b   Debenham, S L ^a,b   Barroso, I ^c   Loos, R J F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Diabetes; Genetic association; Mendelian randomisation

Indexed keywords

INSULIN;

DISEASE MARKER; GENETIC VARIABILITY; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 37549025830     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0903-x     Document Type: Note

References (17)

1. Davey Smith G, Ebrahim S (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1-22
2. Clayton D, McKeigue PM (2001) Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356-1360
3. Herder C, Klopp N, Baumert J et al (2008) Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia DOI 10.1007/s00125-007-0800-3
4. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
5. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G (2007) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med DOI 10.1002/sim.3034
6. Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, Leon DA (2006) Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol 163:397-403
7. Hingorani A, Humphries S (2005) Nature's randomised trials. Lancet 366:1906-1908
8. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365:224-232
9. Timpson NJ, Lawlor DA, Harbord RM et al (2005) C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366:1954-1959
10. Minelli C, Thompson JR, Tobin MD, Abrams KR (2004) An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am J Epidemiol 160:445-452
11. Tobin MD, Minelli C, Burton PR, Thompson JR (2004) Commentary: development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'. Int J Epidemiol 33:26-29
12. Chanock SJ, Manolio T, Boehnke M et al (2007) Replicating genotype-phenotype associations. Nature 447:655-660
13. Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657-662
14. Egger M, Schneider M, Davey Smith G (1998) Spurious precision? Meta-analysis of observational studies. BMJ 316:140-144
15. Casas JP, Shah T, Cooper J et al (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922-931
16. Higgins JP, Little J, Ioannidis JP et al (2007) Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol 166:863-866
17. Davey Smith G, Ebrahim S (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 330:1076-1079